Medical University Vienna
Vienna, State of Vienna, 1090, Austria
NCT Number: NCT05902013
The aim of this study is to perform a pilot study investigating the first attempt intubation success rate differing between video laryngoscope nasotracheal intubation and direct laryngoscope nasotracheal intubation.
The study population will consist of 60 neonates and infants with congenital heart disease less than 1 year of age who need nasotracheal intubation during general anesthesia for cardiac procedures.
Standard nasotracheal intubation will be performed using either a video laryngoscope or direct laryngoscopy. Neonates and infants will be randomly assigned (1:1) to standard video laryngoscopy (with one of the following systems: Storz C-MAC Miller Video Laryngoscope, Karl Storz, Tuttlingen, Germany or Mc Grath Video Laryngoscope, Medtronic, Boulder,USA) or to direct laryngoscopy with one of the following blades: Miller or Macintosh (Heine, Hersching, Germany).
Looking for future studies?
Notify Me0 day–1 year
All sexes
Interventional
Not applicable
Vienna, State of Vienna, 1090, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.
Exclusion criteria
laryngoscopy for nasotracheal intubation
Time frame: study period, 30 minutes
number
Medical University of Vienna
Other
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation in Neonates and Infants With Congenital Heart Disease Less Than 1-year of Age Prior Cardiac Surgery: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01952171
Cardiovascular Abnormalities, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06650787
Cardiovascular Abnormalities, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05524324
Cardiovascular Abnormalities, Cardiovascular Diseases
Caen, France
View Trial DetailsNCT06945003
Behavior, Cardiovascular Abnormalities
Belfast, United Kingdom
View Trial Details